Astra Zeneca COVID-19 vaccine: advice on benefits and risks

The Joint Committe on Vaccines and Immunisation (JCVI) is an independent body of experts that advises the Government on vaccine safety. It has published new advice on the use of the Astra Zeneca COVID-19 vaccine, in the light of some evidence that there may be an very small increased risk of blood clots in some groups. You can read it in full here.

It is important to understand that the benefits of this vaccine vastly outweigh the very small risk. With this in mind, the government has issued advice on vaccine suitability for different groups: you can read their leaflet for patients here. The vast majority of people with a history of blood clots will still be eligible for the AZ vaccine.

The practice reception team will not be able to address specific concerns about the AZ vaccination. We expect to identify those affected by these changes over the next few weeks. Until then, we respectfully ask that you do not request a routine appointment to discuss whether this affects you, as this will overwhelm our booking system and prevent us providing care to those in immediate need. Be assured that you can also address these concerns at your vaccination appointment and will not be offered the AZ vaccine unless the clinicans on site are certain this is in your best interest.

Things are changing quickly and we will continue to update this information as more details become availalbe. Thank you for your patience and support.